-
1
-
-
0037813859
-
-
Rochester: Mayo Foundation for Medical Education and Research
-
Owen CA. A history of blood coagulation. Rochester: Mayo Foundation for Medical Education and Research; 2001. P. 264-7.
-
(2001)
A History of Blood Coagulation
, pp. 264-267
-
-
Owen, C.A.1
-
4
-
-
0027937629
-
Assessment of therapeutical quality control in a long-term anticoagulant trial in post-myocardial infarction patients
-
Azar AJ, Deckers JW, Rosendaal FR, Bergen PFMM van, Meer FJM van der, Jonker JJC, et al. Assessment of therapeutical quality control in a long-term anticoagulant trial in post-myocardial infarction patients. Thromb Haemost 1994;72:347-51.
-
(1994)
Thromb Haemost
, vol.72
, pp. 347-351
-
-
Azar, A.J.1
Deckers, J.W.2
Rosendaal, F.R.3
Van Bergen, P.F.M.M.4
Van Der Meer, F.J.M.5
Jonker, J.J.C.6
-
5
-
-
0027948583
-
Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: Optimal therapeutic range and practical limitations
-
CABADAS Research Group of the Interuniversity Cardiology Institute of the Netherlands
-
Meer J van der, Hillege HL, Dunselman PH, Mulder BJ, Michels HR, Buser PT, et al. Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: optimal therapeutic range and practical limitations. CABADAS Research Group of the Interuniversity Cardiology Institute of the Netherlands. Thromb Haemost 1994;72:676-81.
-
(1994)
Thromb Haemost
, vol.72
, pp. 676-681
-
-
Van Der Meer, J.1
Hillege, H.L.2
Dunselman, P.H.3
Mulder, B.J.4
Michels, H.R.5
Buser, P.T.6
-
6
-
-
0029072271
-
Optimal oral anticoagulant therapy in patients with mechanical heart valves
-
Cannegieter SC, Rosendaal FR, Wintzen AR, Meer FJM van der, Vandenbroucke JP, Briët E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333: 11-7.
-
(1995)
N Engl J Med
, vol.333
, pp. 11-17
-
-
Cannegieter, S.C.1
Rosendaal, F.R.2
Wintzen, A.R.3
Van Der Meer, F.J.M.4
Vandenbroucke, J.P.5
Briët, E.6
-
7
-
-
0031455701
-
A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
-
The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997; 42:857-65.
-
(1997)
Ann Neurol
, vol.42
, pp. 857-865
-
-
-
8
-
-
0035099824
-
Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery
-
Dutch BOA Study Group
-
Tangelder MJD, Algra A, Lawson JA, Hennekes S, Eikelboom BC. Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery. Dutch BOA Study Group. J Vasc Surg 2001;33:522-7.
-
(2001)
J Vasc Surg
, vol.33
, pp. 522-527
-
-
Tangelder, M.J.D.1
Algra, A.2
Lawson, J.A.3
Hennekes, S.4
Eikelboom, B.C.5
-
9
-
-
0035128599
-
Antithrombotic therapy in atrial fibrillation
-
Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001;119: 194S-206S.
-
(2001)
Chest
, vol.119
-
-
Albers, G.W.1
Dalen, J.E.2
Laupacis, A.3
Manning, W.J.4
Petersen, P.5
Singer, D.E.6
-
10
-
-
0042387879
-
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation
-
Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby NV, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003;349:1019-26.
-
(2003)
N Engl J Med
, vol.349
, pp. 1019-1026
-
-
Hylek, E.M.1
Go, A.S.2
Chang, Y.3
Jensvold, N.G.4
Henault, L.E.5
Selby, N.V.6
-
11
-
-
0037202697
-
Antistollingsbehandeling bij patiënten met boezemfibrilleren: Afhankelijk van leeftijd en andere risicofactoren voor trombo-embolie
-
Vink R, Brink RBA van den, Levi M. Antistollingsbehandeling bij patiënten met boezemfibrilleren: afhankelijk van leeftijd en andere risicofactoren voor trombo-embolie. Ned Tijdschr Geneeskd 2003; 146:2285-9.
-
(2003)
Ned Tijdschr Geneeskd
, vol.146
, pp. 2285-2289
-
-
Vink, R.1
Van Den Brink, R.B.A.2
Levi, M.3
-
12
-
-
0034460484
-
Effects of warfarin, aspirin and the two combined, on mortality and thromboembolic morbidity after myocardial infarction. The WARIS-II (Warfarin-Aspirin Reinfarction Study) design
-
Hurlen M, Smith P, Arnesen H. Effects of warfarin, aspirin and the two combined, on mortality and thromboembolic morbidity after myocardial infarction. The WARIS-II (Warfarin-Aspirin Reinfarction Study) design. Scand Cardiovasc J 2000;34:168-71.
-
(2000)
Scand Cardiovasc J
, vol.34
, pp. 168-171
-
-
Hurlen, M.1
Smith, P.2
Arnesen, H.3
-
13
-
-
0037072090
-
Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): A randomised controlled trial
-
Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 (ASPECT-2) Research Group
-
Es RF van, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE. Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 (ASPECT-2) Research Group. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet 2002;360:109-13.
-
(2002)
Lancet
, vol.360
, pp. 109-113
-
-
Van Es, R.F.1
Jonker, J.J.2
Verheugt, F.W.3
Deckers, J.W.4
Grobbee, D.E.5
-
14
-
-
0031001452
-
Efficacy and safety of lower molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery; a meta-analysis of randomised clinical trials
-
Palmer AJ, Koppenhagen K, Kirchhof B, Weber U, Bergemann R. Efficacy and safety of lower molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery; a meta-analysis of randomised clinical trials. Haemostasis 1997;27:75-84.
-
(1997)
Haemostasis
, vol.27
, pp. 75-84
-
-
Palmer, A.J.1
Koppenhagen, K.2
Kirchhof, B.3
Weber, U.4
Bergemann, R.5
-
15
-
-
0035125403
-
Managing oral anticoagulant therapy
-
Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Managing oral anticoagulant therapy. Chest 2001;119:22S-38S.
-
(2001)
Chest
, vol.119
-
-
Ansell, J.1
Hirsh, J.2
Dalen, J.3
Bussey, H.4
Anderson, D.5
Poller, L.6
-
16
-
-
0037068999
-
Bleeding risks of anti-thrombotic therapy
-
Fitzmaurice DA, Blann AD, Lip GYH. Bleeding risks of anti-thrombotic therapy. BMJ 2002;325:828-31.
-
(2002)
BMJ
, vol.325
, pp. 828-831
-
-
Fitzmaurice, D.A.1
Blann, A.D.2
Lip, G.Y.H.3
-
18
-
-
15844427401
-
Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy
-
Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348:423-8.
-
(1996)
Lancet
, vol.348
, pp. 423-428
-
-
Palareti, G.1
Leali, N.2
Coccheri, S.3
Poggi, M.4
Manotti, C.5
D'Angelo, A.6
-
19
-
-
0036283541
-
Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon
-
Gadisseur APA, Meer FJM van der, Adriaansen HJ, Fihn SD, Rosendaal FR. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon. Br J Haematol 2002;117:940-6.
-
(2002)
Br J Haematol
, vol.117
, pp. 940-946
-
-
Gadisseur, A.P.A.1
Van Der Meer, F.J.M.2
Adriaansen, H.J.3
Fihn, S.D.4
Rosendaal, F.R.5
-
20
-
-
0034603468
-
Postoperatieve wondinfecties: Een bruikbare indicator voor de kwaliteit van zorg?
-
Casparie AF. Postoperatieve wondinfecties: een bruikbare indicator voor de kwaliteit van zorg? Ned Tijdschr Geneeskd 2000;144:460-2.
-
(2000)
Ned Tijdschr Geneeskd
, vol.144
, pp. 460-462
-
-
Casparie, A.F.1
-
21
-
-
0011705769
-
Paradigma's van kwaliteit
-
Berg M, Schellekens W. Paradigma's van kwaliteit. Med Contact 2002;57:1203-6.
-
(2002)
Med Contact
, vol.57
, pp. 1203-1206
-
-
Berg, M.1
Schellekens, W.2
-
22
-
-
0035576054
-
Zelfcontrole en -dosering van orale antistollingsbehandeling met vitamine-K-antagonisten
-
Levi M, Bruin TA de, Meer FJ van der, Cromheecke ME, Mol BAJM de. Zelfcontrole en -dosering van orale antistollingsbehandeling met vitamine-K-antagonisten. Ned Tijdschr Geneeskd 2001; 145:2313-7.
-
(2001)
Ned Tijdschr Geneeskd
, vol.145
, pp. 2313-2317
-
-
Levi, M.1
De Bruin, T.A.2
Van Der Meer, F.J.3
Cromheecke, M.E.4
De Mol, B.A.J.M.5
|